301015 百洋醫藥
按盤價 
26.890 +1.690 (+6.706%)
26.890 +1.690 (+6.706%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.907 | 19.623 | 26.267 | 27.425 | 22.722 |
| 總資產報酬率 ROA (%) | 1.486 | 6.236 | 10.223 | 12.440 | 10.518 |
| 投入資產回報率 ROIC (%) | 1.869 | 8.070 | 13.686 | 15.948 | 12.901 | 邊際利潤分析 |
| 銷售毛利率 (%) | 39.479 | 37.471 | 35.503 | 33.295 | 27.761 |
| 營業利潤率 (%) | 10.877 | 9.808 | 12.079 | 12.641 | 8.979 |
| 息稅前利潤/營業總收入 (%) | 12.561 | 11.065 | 12.820 | 13.246 | 9.547 |
| 淨利潤/營業總收入 (%) | 8.715 | 7.619 | 9.476 | 9.335 | 6.523 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 102.823 | 92.156 | 95.706 | 97.201 | 101.354 |
| 價值變動淨收益/利潤總額(%) | 3.317 | 12.857 | 6.303 | 4.398 | -1.327 |
| 營業外收支淨額/利潤總額(%) | -0.234 | -1.838 | -1.149 | -1.519 | -0.854 | 償債能力分析 |
| 流動比率 (X) | 1.429 | 1.438 | 1.569 | 2.140 | 1.635 |
| 速動比率 (X) | 1.176 | 1.212 | 1.284 | 1.780 | 1.386 |
| 資產負債率 (%) | 66.169 | 66.201 | 63.379 | 51.391 | 54.688 |
| 帶息債務/全部投入資本 (%) | 59.905 | 59.734 | 52.596 | 37.059 | 40.604 |
| 股東權益/帶息債務 (%) | 63.553 | 63.788 | 85.200 | 162.285 | 137.491 |
| 股東權益/負債合計 (%) | 45.664 | 45.865 | 52.683 | 87.660 | 83.671 |
| 利息保障倍數 (X) | 7.349 | 7.717 | 14.594 | 16.668 | 14.817 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 70.960 | 80.101 | 90.461 | 91.822 | 93.134 |
| 存貨周轉天數 (天) | 82.535 | 69.923 | 61.697 | 49.412 | 42.270 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 14/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
